Suja Life, Inc. Reports Robust Q1 2026 Financial Results: Major Growth and Key Investor Insights
Summary of Key Financial Highlights
- Net Sales Surge: Suja Life, Inc. reported a remarkable 22.5% year-over-year increase in net sales, reaching \$107.1 million for the first quarter of 2026.
- Substantial Profitability Improvement: Net income for Q1 2026 was \$7.7 million, a significant turnaround from a net loss of \$0.8 million in the prior year period.
- Strong EBITDA and Adjusted EBITDA Growth:
- EBITDA reached \$23.4 million for Q1 2026, up from \$6.9 million in Q1 2025.
- Adjusted EBITDA increased to \$25.0 million, compared to \$15.0 million a year ago.
- Margin Expansion:
- Net income margin improved to 7.2%, up from -0.9% in Q1 2025.
- Adjusted EBITDA margin expanded to 23.4%, compared to 17.2% in Q1 2025.
- EBITDA margin was 21.9%, up from 16.6% in the prior year period.
2026 Outlook and Guidance
- Full-Year 2026 Adjusted EBITDA Guidance: Suja Life expects Adjusted EBITDA for the full year 2026 to be in the range of \$70 million to \$72 million, reflecting an impressive growth rate of 72.8% to 77.7% compared to 2025’s Adjusted EBITDA of \$40.5 million.
- Effective Tax Rate: The company projects a 2026 effective tax rate of 27.4%.
- Interest Expense (Net): Anticipated to be approximately \$19.0 million for the year ending December 28, 2026.
Note: The company is unable to provide a reconciliation for the forward-looking outlook of Adjusted EBITDA to net income (loss) due to the inability to reasonably estimate certain reconciling items.
Operational and Strategic Updates
- Suja Life continues to experience strong demand for its portfolio of organic juices, wellness shots, and functional sodas.
- The company is actively investing in corporate strategy, executive recruiting, and consulting related to its IPO, with certain one-time costs recognized in Q1 2026.
- Fees paid to Paine Schwartz Partners, a sponsor, were recognized but will not recur after the IPO.
Liquidity and Capital Position
- Cash and Restricted Cash: Ended Q1 2026 with \$28.4 million in cash and restricted cash, compared to \$32.0 million at year-end 2025.
- Operating Cash Flow: Generated \$6.2 million in net cash from operating activities in Q1 2026, versus a cash outflow of \$(3.8) million in Q1 2025.
- Investing Activities: Net cash used in investing activities was \$(9.1) million in Q1 2026, primarily for property, equipment, and intangible assets.
- Financing Activities: Net cash used in financing activities was \$(0.7) million.
Balance Sheet Notes
- Total Assets: \$428.1 million as of March 30, 2026.
- Total Liabilities: \$395.5 million.
- Total Partners’ Equity: \$7.5 million.
- Accumulated Deficit: \$(104.4) million.
Non-GAAP Financial Measures and Definitions
- EBITDA: Defined as net income (loss) excluding tax expense, net interest expense, and depreciation and amortization.
- Adjusted EBITDA: Further excludes share-based compensation, IPO-related costs, non-recurring sponsor fees, and other one-time expenses.
- Adjusted EBITDA Margin: Adjusted EBITDA divided by net sales.
- Management believes these measures enhance comparability and transparency for investors, though they are not a substitute for GAAP metrics.
Important Shareholder Considerations and Potential Share Price Impact
- Return to Profitability: The shift from a net loss to net income, along with strong margin expansion, is likely to be viewed favorably by investors and could be a significant share price catalyst.
- Robust Guidance: The company’s bullish outlook for Adjusted EBITDA growth of over 70% in 2026 may positively influence investor sentiment and valuation multiples.
- IPO-Related Non-Recurring Costs: One-time IPO-related expenses and sponsor fees will not recur, indicating that underlying profitability could further improve in future periods.
- Potential Risks: The company highlights risks related to the supply of organic fruits and vegetables, inflationary pressures, and the success of its marketing and expansion strategies. Any adverse developments in these areas could impact future results and share value.
- Emerging Growth Company Status: Suja Life is classified as an “emerging growth company,” which may provide certain regulatory and reporting advantages but may also come with increased volatility as the company scales.
Forward-Looking Statements and Cautionary Notes
The report and press release contain forward-looking statements, including projections of costs, expenditures, cash flows, growth rates, financial guidance, and strategic objectives. These statements are subject to risks, including inflation, supply chain, consumer demand, and the ability to execute on growth initiatives. Actual results may differ materially from current expectations.
Conference Call Information
Suja Life will host a conference call and webcast at 4:30 p.m. Eastern Time on June 9, 2026, to discuss the results.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Forward-looking statements are inherently subject to risks and uncertainties. Investors should consult official SEC filings and company releases for further details and consider their own circumstances before making investment decisions.
